Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Meridian Bioscience, Inc.
Patients with chronic liver disease who have a recent biopsy will be offered a breath test. Correlation will be shown between histology and breath test in determining cirrhosis.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age \>18 with chronic liver disease
You may not be if
Patients that are taking hepatotoxin drug.
Patient with severe congestive heart failure
Patient with severe pulmonary hypertension
Patient with uncontrolled diabetes mellitus
Patient with previous surgical bypass surgery for morbid obesity
Patient with extensive small bowel resection
Patient currently receiving total parenteral nutrition
Patient is a recipients of any organ transplant
Patients that received any anti-viral treatment within the past year
Women who are pregnant
Patient allergic to acetaminophen (such as Tylenol or any other related medications)
Patient with history of chronic obstructive pulmonary disease or symptomatic bronchial asthma
Patients unable to sign informed consent
Patients that based on the opinion of the investigator should not be enrolled into this study
Patients that are participating in other clinical trials evaluating experimental treatments or procedures
Clareo Health | BreathID 13C-Methacetin Breath Test for Detecting Cirrhosis
